JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan · Delayed Price · Currency is JPY 620.00
+24.00 (4.03%)
Mar 5, 2026, 3:30 PM JST
JCR Pharmaceuticals Market Cap
JCR Pharmaceuticals has a market cap or net worth of 72.7 billion as of March 5, 2026. Its market cap has increased by 23.56% in one year.
Market Cap
72.70B
Enterprise Value
110.10B
Revenue
37.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
620.00
Market Cap Chart
Since March 22, 2011, JCR Pharmaceuticals's market cap has increased from 28.73B to 72.70B, an increase of 153.06%. That is a compound annual growth rate of 6.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 72.70B | -16.29% |
| Dec 30, 2025 | 86.85B | 17.45% |
| Dec 30, 2024 | 73.95B | -49.44% |
| Dec 29, 2023 | 146.26B | -30.27% |
| Dec 30, 2022 | 209.74B | -23.79% |
| Dec 30, 2021 | 275.22B | -8.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 16.70T |
| Otsuka Holdings | 5.51T |
| Daiichi Sankyo Company | 5.42T |
| Astellas Pharma | 4.66T |
| Kyowa Kirin | 1.47T |
| Ono Pharmaceutical | 1.20T |
| Santen Pharmaceutical | 553.11B |
| Perseus Proteomics | 3.41B |